PierianDx company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

pieriandx.com

Executives

18

Board of Directors

3

PierianDx Board of Directors

3 Board of directors

PierianDx has 3 board of directors, including Bryan Carey.

Name

Firm

Work History

Other Seats

Bryan Carey

PierianDx

Cody Nystrom

Cody Nystrom is a Managing Director at SJF Ventures. She joined SJF in the Durham, North Carolina office in 2007 and leads SJF’s health and wellness investment practice. Cody currently represents SJF on the boards of Ellipsis Health (mental health machine learning software), Take Command Health (health reimbursement software), PierianDx (clinical genomics software), mPulse Mobile (mobile healthcare engagement platform), TemperPack (sustainable thermal packaging solutions), Solera Health (preventative and community health network), Validic (mobile health data platform), and Cecelia Health (clinician coaching solutions for chronic conditions). Cody previously represented SJF on the boards of Versify Solutions, Community Energy, Inc., Vital Farms, and CleanScapes. Cody also serves on advising committees for Lighthouse Labs, Commonwealth Energy Fund, and the Virginia Solar Energy Development and Energy Storage Authority. Cody was previously at Ewing Bemiss & Co., an investment bank based in Richmond, Virginia that provides M&A and other financial advisory services to middle-market companies, primarily in the energy and healthcare services sectors. Cody graduated summa cum laude from the University of Virginia with a BS in Systems and Information Engineering and a minor in Business.

PierianDx

Joseph Boorady

Experienced Chief Executive Officer with a demonstrated history of working in the medical device industry. Skilled in Marketing Management, Market Planning, Sales, Medical Devices, and Sales Operations. Strong business development professional with a Alumnus focused in Business from Harvard Business School Executive Education.

PierianDx

Name

Bryan Carey

Cody Nystrom

Joseph Boorady

Firm

Work History

Cody Nystrom is a Managing Director at SJF Ventures. She joined SJF in the Durham, North Carolina office in 2007 and leads SJF’s health and wellness investment practice. Cody currently represents SJF on the boards of Ellipsis Health (mental health machine learning software), Take Command Health (health reimbursement software), PierianDx (clinical genomics software), mPulse Mobile (mobile healthcare engagement platform), TemperPack (sustainable thermal packaging solutions), Solera Health (preventative and community health network), Validic (mobile health data platform), and Cecelia Health (clinician coaching solutions for chronic conditions). Cody previously represented SJF on the boards of Versify Solutions, Community Energy, Inc., Vital Farms, and CleanScapes. Cody also serves on advising committees for Lighthouse Labs, Commonwealth Energy Fund, and the Virginia Solar Energy Development and Energy Storage Authority. Cody was previously at Ewing Bemiss & Co., an investment bank based in Richmond, Virginia that provides M&A and other financial advisory services to middle-market companies, primarily in the energy and healthcare services sectors. Cody graduated summa cum laude from the University of Virginia with a BS in Systems and Information Engineering and a minor in Business.

Experienced Chief Executive Officer with a demonstrated history of working in the medical device industry. Skilled in Marketing Management, Market Planning, Sales, Medical Devices, and Sales Operations. Strong business development professional with a Alumnus focused in Business from Harvard Business School Executive Education.

Other Seats

PierianDx

PierianDx

PierianDx

PierianDx Management Team

18 Team Members

PierianDx has 18 executives. PierianDx's founder is Jeffrey D. Millbrandt. PierianDx's current Founder, President is Rakesh Nagarajan.

Name

Work History

Title

Status

Jeffrey D. Millbrandt

Founder

Current

Rakesh Nagarajan

Founder, President

Current

John D. Pfeifer

Founder

Current

Karen Seibert

Founder

Current

Herbert W. Virgin

Founder

Current

Name

Jeffrey D. Millbrandt

Rakesh Nagarajan

John D. Pfeifer

Karen Seibert

Herbert W. Virgin

Work History

Title

Founder

Founder, President

Founder

Founder

Founder

Status

Current

Current

Current

Current

Current

You May Also Like

N
Navican Genomics

Navican provides a personalized approach to testing, diagnosing, and treating cancer. The company's unique process analyzes the genetic makeup of a patient's cancer and employs a team of skilled molecular tumor specialists to review each test and determine how to most effectively treat that cancer case.

Tempus Logo
Tempus

Tempus builds a library of molecular and clinical data as well as a corresponding operating system for data accessibility and use. The company enables physicians to deliver personalized cancer care for patients through its interactive analytical and machine learning platform. It provides genomic sequencing services and molecular and therapeutic data analysis to empower physicians to make real-time, data-driven decisions.

Fabric Genomics Logo
Fabric Genomics

Fabric Genomics, formerly Omicia, is a computational genomics company offering end-to-end genomic data analysis, annotation, curation, classification and reporting solutions to clinical labs, hospital labs, country sequencing programs and life science companies. Fabric Genomics' analytic capabilities begin with raw data analysis and include the delivery of rapid, comprehensive insights for high throughout panels, exomes, and whole genomes. The company can process any NGS file input (e.g. FASTQ, BAM or VCF) providing alignment, variant calling, annotation, guideline-driven variant classification, variant interpretation and clinical reporting for both hereditary disease and oncology. Fabric Genomics was founded by scientists and industry pioneers in bioinformatics, large-scale genomics and molecular diagnostics, and is headquartered in Oakland, California with satellite offices in London, Seattle, Salt Lake City and Boston. By accelerating access to insights related to the cause of genetic diseases, Fabric Genomics is leading the way in precision healthcare.

Gene42 Logo
Gene42

Gene42 is a medical technology and clinical software company that develops clinical software tools for collecting and analyzing phenotypic information for patients with genetic disorders and cancers. Their solution, PhenoTips, allows for efficient recording of patient data in a standardized format, which facilitates automated searches of annotated genes and disease databases (differential diagnosis), enables effortless querying and sharing of anonymized patient data by users and provides a user-friendly interface with advanced features that reduces clinician's workload and seamlessly integrates into clinical work flow. Gene42 provides support contracts and custom development for PhenoTips software. Data organization when it comes to patient care is critical, especially in rare diseases when certain symptoms or features of a disease might not be seen on a regular basis. In the age of "big data" and electronic health records, Gene42 is striving to make personalized medicine more effective for patients and their doctors.

Q
Q-State Biosciences

Q-State Biosciences is a precision medicine company creating new genetically targeted medicines for people living with nervous system disorders. The company's proprietary ResQueTM Platform incorporates a suite of technologies to map each patient’s unique genome to a genetic therapy that targets the root cause of disease.

Illumina Logo
Illumina

Illumina works to apply new technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic. The company was founded in 1998 and is based in San Diego, California.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.